PMVP Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-01-18 | Jalota Deepika | officer: Chief Development Officer | 225,095 | A-Award | A | 225,095 | 1.80 | 405,171.00 |
| 2024-01-18 | Jalota Deepika | officer: Chief Development Officer | 125,501 | A-Award | A | 95,555 | 0.00 | 0.00 |
| 2024-01-18 | Carulli Michael | officer: Chief Financial Officer | 204,630 | A-Award | A | 204,630 | 1.80 | 368,334.00 |
| 2024-01-18 | Carulli Michael | officer: Chief Financial Officer | 91,286 | A-Award | A | 82,220 | 0.00 | 0.00 |
| 2024-01-18 | Mack David Henry | director, officer: President and CEO | 519,915 | A-Award | A | 519,915 | 1.80 | 935,847.00 |
| 2024-01-18 | Mack David Henry | director, officer: President and CEO | 442,460 | A-Award | A | 163,890 | 0.00 | 0.00 |
| 2024-01-05 | Carulli Michael | officer: Chief Financial Officer | 9,066 | D | 0 | 0.00 | 0.00 | |
| 2024-01-05 | Carulli Michael | officer: Chief Financial Officer | 0 | D | 13,605 | 28.33 | 385,430.00 | |
| 2024-01-05 | Carulli Michael | officer: Chief Financial Officer | 0 | D | 24,632 | 4.22 | 103,947.00 | |
| 2024-01-05 | Carulli Michael | officer: Chief Financial Officer | 0 | D | 27,200 | 16.29 | 443,088.00 | |
| 2024-01-05 | Carulli Michael | officer: Chief Financial Officer | 0 | D | 75,000 | 5.70 | 427,500.00 | |
| 2023-11-22 | ORBIMED ADVISORS LLC | 10 percent owner | 0 | S-Sale | D | 87,786 | 2.23 | 195,763.00 |
| 2023-10-18 | Mack David Henry | director, officer: President and CEO | 363,877 | M-Exempt | A | 198,407 | 0.53 | 105,156.00 |
| 2023-11-10 | Mack David Henry | director, officer: President and CEO | 278,570 | G-Gift | D | 85,307 | 0.00 | 0.00 |
| 2023-11-10 | Mack David Henry | director, officer: President and CEO | 165,307 | G-Gift | A | 85,307 | 0.00 | 0.00 |
| 2023-08-07 | Mack David Henry | director, officer: President and CEO | 109,459 | M-Exempt | D | 198,407 | 0.53 | 105,156.00 |
| 2023-09-15 | Jalota Deepika | officer: Chief Development Officer | 29,946 | S-Sale | D | 4,104 | 6.62 | 27,168.00 |
| 2023-09-15 | Alland Leila | officer: Chief Medical Officer | 45,909 | S-Sale | D | 6,291 | 6.62 | 41,646.00 |
| 2023-08-07 | Mack David Henry | director, officer: President and CEO | 307,866 | M-Exempt | D | 85,500 | 0.53 | 45,315.00 |
| 2023-08-07 | Mack David Henry | director, officer: President and CEO | 165,470 | M-Exempt | A | 85,500 | 0.53 | 45,315.00 |
| 2023-06-08 | Stelzer Laurie | director | 21,500 | A-Award | A | 21,500 | 5.59 | 120,185.00 |
| 2023-06-08 | LEVINE ARNOLD J | director | 21,500 | A-Award | A | 21,500 | 5.59 | 120,185.00 |
| 2023-06-08 | Heyman Richard A. | director | 21,500 | A-Award | A | 21,500 | 5.59 | 120,185.00 |
| 2023-06-08 | Gallagher Carol Giltner | director | 21,500 | A-Award | A | 21,500 | 5.59 | 120,185.00 |
| 2023-06-08 | Gallagher Carol Giltner | director | 21,500 | G-Gift | A | 21,500 | 5.59 | 120,185.00 |
| 2023-06-08 | Gallagher Carol Giltner | director | 0 | G-Gift | D | 21,500 | 5.59 | 120,185.00 |
| 2023-06-08 | FLOWERS KIRSTEN | director | 21,500 | A-Award | A | 21,500 | 5.59 | 120,185.00 |
| 2023-06-08 | BAUM CHARLES M | director | 21,500 | A-Award | A | 21,500 | 5.59 | 120,185.00 |
| 2023-05-12 | Jalota Deepika | officer: Chief Development Officer | 125,000 | A-Award | A | 125,000 | 5.70 | 712,500.00 |
| 2023-05-12 | Alland Leila | officer: Chief Medical Officer | 100,000 | A-Award | A | 100,000 | 5.70 | 570,000.00 |
| 2023-05-12 | Kung Winston | officer: COO, CFO | 150,000 | A-Award | A | 150,000 | 5.70 | 855,000.00 |
| 2023-05-12 | Mack David Henry | director, officer: President and CEO | 330,000 | A-Award | A | 330,000 | 5.70 | 1,881,000.00 |
| 2022-11-25 | Kung Winston | officer: COO, CFO | 10,600 | G-Gift | D | 2,560 | 0.00 | 0.00 |
| 2022-11-04 | Gallagher Carol Giltner | director | 39,000 | A-Award | A | 39,000 | 0.00 | 0.00 |
| 2022-11-05 | Gallagher Carol Giltner | director | 39,000 | G-Gift | A | 39,000 | 0.00 | 0.00 |
| 2022-11-03 | Gallagher Carol Giltner | None | 0 | None | None | 0.00 | ||
| 2022-11-03 | Gallagher Carol Giltner | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2022-06-02 | Stelzer Laurie | director: | 19,500 | A-Award | D | 19,500 | 0.00 | 0.00 |
| 2022-06-02 | Stelzer Laurie | director | 19,500 | A-Award | D | 19,500 | 13.56 | 264,420.00 |
| 2022-06-02 | LEVINE ARNOLD J | director: | 19,500 | A-Award | A | 19,500 | 0.00 | 0.00 |
| 2022-06-02 | LEVINE ARNOLD J | director | 19,500 | A-Award | A | 19,500 | 13.56 | 264,420.00 |
| 2022-06-02 | Heyman Richard A. | director: | 19,500 | A-Award | A | 19,500 | 0.00 | 0.00 |
| 2022-06-02 | Heyman Richard A. | director | 19,500 | A-Award | A | 19,500 | 13.56 | 264,420.00 |
| 2022-06-02 | FLOWERS KIRSTEN | director: | 19,500 | A-Award | A | 19,500 | 0.00 | 0.00 |
| 2022-06-02 | FLOWERS KIRSTEN | director | 19,500 | A-Award | A | 19,500 | 13.56 | 264,420.00 |
| 2022-06-02 | BAUM CHARLES M | director: | 19,500 | A-Award | A | 19,500 | 0.00 | 0.00 |
| 2022-06-02 | BAUM CHARLES M | director | 19,500 | A-Award | A | 19,500 | 13.56 | 264,420.00 |
| 2022-05-26 | ORBIMED ADVISORS LLC | 10 percent owner | 87,786 | S-Sale | D | 26,253 | 15.93 | 418,210.00 |
| 2022-05-26 | OrbiMed Genesis GP LLC | director: | 87,786 | S-Sale | D | 26,253 | 15.93 | 418,210.00 |
| 2022-04-27 | Mack David Henry | officer: President and CEO | 393,366 | M-Exempt | D | 33,000 | 0.00 | 0.00 |
| 2022-04-27 | Mack David Henry | director, officer: President and CEO | 393,366 | M-Exempt | D | 33,000 | 0.53 | 17,490.00 |
| 2022-04-27 | Mack David Henry | director, officer: President and CEO | 79,970 | M-Exempt | A | 33,000 | 0.53 | 17,490.00 |
| 2022-04-20 | Kung Winston | officer: COO, CFO | 210,034 | M-Exempt | D | 4,000 | 0.00 | 0.00 |
| 2022-04-20 | Kung Winston | officer: COO, CFO | 210,034 | M-Exempt | D | 4,000 | 3.22 | 12,880.00 |
| 2022-04-20 | Kung Winston | officer: COO, CFO | 10,600 | M-Exempt | A | 4,000 | 3.22 | 12,880.00 |
| 2022-03-29 | ORBIMED ADVISORS LLC | 10 percent owner | 109,500 | S-Sale | D | 365,000 | 21.52 | 7,854,800.00 |
| 2022-03-29 | ORBIMED CAPITAL LLC | director: | 109,500 | S-Sale | D | 365,000 | 21.52 | 7,854,800.00 |
| 2022-03-30 | ORBIMED ADVISORS LLC | 10 percent owner | 34,500 | S-Sale | D | 75,000 | 22.39 | 1,679,250.00 |
| 2022-03-31 | ORBIMED ADVISORS LLC | 10 percent owner | 0 | S-Sale | D | 34,500 | 21.17 | 730,365.00 |
| 2022-03-08 | Mack David Henry | director, officer: President and CEO | 220,644 | M-Exempt | D | 20,000 | 1.37 | 27,400.00 |
| 2022-03-08 | Mack David Henry | officer: President and CEO | 147,915 | G-Gift | D | 40,000 | 0.00 | 0.00 |
| 2021-03-09 | Mack David Henry | director, officer: President and CEO | 80,000 | G-Gift | A | 40,000 | 0.00 | 0.00 |
| 2022-03-08 | Mack David Henry | officer: President and CEO | 46,970 | M-Exempt | A | 20,000 | 1.37 | 27,400.00 |
| 2022-02-10 | Jalota Deepika | officer: SVP, Regulatory Affairs and QA | 68,100 | A-Award | A | 68,100 | 16.29 | 1,109,349.00 |
| 2022-02-10 | Alland Leila | officer: Chief Medical Officer | 104,400 | A-Award | A | 104,400 | 16.29 | 1,700,676.00 |
| 2022-02-10 | Kung Winston | officer: COO, CFO | 104,400 | A-Award | A | 104,400 | 16.29 | 1,700,676.00 |
| 2022-02-10 | Mack David Henry | director, officer: President and CEO | 249,600 | A-Award | A | 249,600 | 16.29 | 4,065,984.00 |
| 2021-12-30 | Kung Winston | officer: COO, CFO | 6,600 | G-Gift | D | 2,725 | 0.00 | 0.00 |
| 2021-12-30 | Kung Winston | officer: COO, CFO | 6,600 | G-Gift | D | 2,725 | 0.00 | 0.00 |
| 2022-01-06 | FLOWERS KIRSTEN | director | 32,677 | M-Exempt | A | 32,677 | 19.06 | 622,824.00 |
| 2022-01-06 | FLOWERS KIRSTEN | director | 32,677 | M-Exempt | A | 32,677 | 19.06 | 622,824.00 |
| 2022-01-05 | FLOWERS KIRSTEN | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2021-12-15 | Mack David Henry | director, officer: President and CEO | 432,574 | M-Exempt | D | 9,000 | 0.53 | 4,770.00 |
| 2021-12-15 | Mack David Henry | officer: President and CEO | 432,574 | M-Exempt | D | 9,000 | 0.53 | 4,770.00 |
| 2021-12-09 | Mack David Henry | officer: President and CEO | 187,915 | G-Gift | D | 40,000 | 0.00 | 0.00 |
| 2021-12-09 | Mack David Henry | director, officer: President and CEO | 187,915 | G-Gift | D | 40,000 | 0.00 | 0.00 |
| 2021-12-09 | Mack David Henry | director, officer: President and CEO | 40,000 | G-Gift | A | 40,000 | 0.00 | 0.00 |
| 2021-12-09 | Mack David Henry | officer: President and CEO | 40,000 | G-Gift | A | 40,000 | 0.00 | 0.00 |
| 2021-12-15 | Mack David Henry | officer: President and CEO | 26,970 | M-Exempt | A | 9,000 | 0.53 | 4,770.00 |
| 2021-12-15 | Mack David Henry | director, officer: President and CEO | 26,970 | M-Exempt | A | 9,000 | 0.53 | 4,770.00 |
| 2021-10-06 | Schroeder Thilo | director | 1,101,283 | S-Sale | D | 800 | 30.15 | 24,120.00 |
| 2021-09-30 | Schroeder Thilo | director | 1,113,724 | S-Sale | D | 2,978 | 30.03 | 89,429.00 |
| 2021-10-01 | Schroeder Thilo | director | 1,102,183 | S-Sale | D | 11,541 | 30.10 | 347,384.00 |
| 2021-10-04 | Schroeder Thilo | director | 1,102,083 | S-Sale | D | 100 | 30.08 | 3,008.00 |
| 2021-09-27 | Schroeder Thilo | director | 1,122,410 | S-Sale | D | 1,753 | 30.11 | 52,783.00 |
| 2021-09-29 | Schroeder Thilo | director | 1,116,702 | S-Sale | D | 5,708 | 30.04 | 171,468.00 |
| 2021-09-22 | Schroeder Thilo | director | 1,124,163 | S-Sale | D | 100 | 30.00 | 3,000.00 |
| 2021-09-22 | LEVINE ARNOLD J | director | 409,842 | S-Sale | D | 3,500 | 30.00 | 105,000.00 |
| 2021-09-17 | Schroeder Thilo | director | 1,124,263 | S-Sale | D | 711 | 30.03 | 21,351.00 |
| 2021-09-09 | Schroeder Thilo | director | 1,181,473 | S-Sale | D | 14,329 | 30.31 | 434,312.00 |
| 2021-09-10 | Schroeder Thilo | director | 1,143,417 | S-Sale | D | 38,056 | 30.44 | 1,158,425.00 |
| 2021-09-10 | Schroeder Thilo | director | 1,138,246 | S-Sale | D | 5,171 | 31.03 | 160,456.00 |
| 2021-09-13 | Schroeder Thilo | director | 1,124,974 | S-Sale | D | 13,272 | 30.20 | 400,814.00 |
| 2021-09-09 | Alland Leila | officer: Chief Medical Officer | 353,850 | M-Exempt | D | 100 | 3.90 | 390.00 |
| 2021-09-09 | Alland Leila | officer: Chief Medical Officer | 100 | M-Exempt | A | 100 | 3.90 | 390.00 |
| 2021-09-09 | Alland Leila | officer: Chief Medical Officer | 0 | S-Sale | D | 100 | 30.25 | 3,025.00 |
| 2021-09-07 | Alland Leila | officer: Chief Medical Officer | 353,950 | M-Exempt | D | 3,900 | 3.90 | 15,210.00 |
| 2021-09-07 | Alland Leila | officer: Chief Medical Officer | 3,900 | M-Exempt | A | 3,900 | 3.90 | 15,210.00 |
| 2021-09-07 | Alland Leila | officer: Chief Medical Officer | 0 | S-Sale | D | 3,900 | 30.25 | 117,975.00 |
| 2021-08-31 | Schroeder Thilo | director | 1,223,188 | S-Sale | D | 19,520 | 30.12 | 587,942.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
